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Introduction
In our rapidly ageing population more than 50% of the adult 
population is overweight or obese. A better understanding of 
the influence of ageing and nutritional interventions such as 
dietary restriction is important in order to counteract clinical 
symptoms of obesity and dysregulated metabolism. Obesity 
is a chronic disease that is associated with an increased risk 
of metabolic disorders such as insulin resistance and chronic 
inflammation. It is also a major driver of ageing and the 
development of age-related diseases. Chronic inflammation 
is also an important hallmark of the ageing process and is 
known as “inflammaging” (1). A decrease in body weight 
by nutritional means such as reduction of calories has been 
shown to have many beneficial effects on health and lifespan 
in various model organisms (for review see (2)). Likewise, 
the eradication of senescent cells has shown similar beneficial 
effects in mice (3). 
White adipose tissue (WAT) forms an endocrine organ 
with both positive and negative effects on metabolism. It 
serves as a repository of free fatty acids (FFAs) as an energy 
supply. Storage and lipolysis of lipid droplets for β-oxidation in 
adipocytes are critical regulators of metabolic homeostasis. By 
secreting adipokines, adipocytes regulate metabolism, energy 
intake, and fat storage (4). Adipocytes are known to enlarge 
during obesity and the ageing process (5, 6). In contrast, caloric 
restriction results in decreased body mass, and preferentially 
reduced the mass of different fat depots including up to 78% in 
visceral fat (7-10). Several studies demonstrated that increased 
fat cell size is a significant predictor of altered blood lipid 
profiles and glucose-insulin homeostasis. The contribution of 
visceral adiposity to these associations seems to be of particular 
importance (11).
Senescence and inflammation are two important mechanisms 
contributing to ageing and the metabolic consequences 
of obesity. Inflammation can result from accumulation of 
macrophages in adipose tissue via production of cytokines 
such as TNFα and IL-6 (12, 13). Increase in lipolysis has 
been shown to induce macrophage migration in vitro (14). 
Macrophage numbers in adipose tissue also increase with 
obesity and ageing where they scavenge dead or senescent 
adipocytes and form aggregates and crown-like structures 
(15, 16). However, inflammatory cytokines and chemokines 
are also characteristics of the senescence-associated secretory 
phenotype (SASP) in senescent cells (13). 
We have shown previously that ROS, DNA damage and 
mitochondrial dysfunction are instrumental to maintain 
cellular senescence (17) while eradicating mitochondria from 
fibroblasts significantly delayed the onset of the senescence 
phenotype and downregulated multiple SASP factors (18). 
Various treatments have been suggested to delay senescence 
in adipose tissues while obesity and short telomeres 
exacerbated senescence (19) A recent study showed that 
feeding a high-fat diet ad libitum induced senescence in mouse 
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visceral adipose tissue which could be ameliorated by exercise 
(20). However, DR seems to regulate many more genes than 
exercise in subcutaneous fat in humans (21).
We have demonstrated previously that short-term dietary 
restriction in wild type mice decreased the amount of 
senescent cells in various tissues (22). We hypothesise that 
pro-inflammatory cytokines and senescence are also causally 
related in visceral WAT, increase together during ageing, and 
might be rescued during DR. We used visceral WAT from mice 
of different ages as well as mice on late-onset, short term DR 
(22) to investigate the changes in adipocyte size, accumulation 
of γH2A.X DNA damage foci during ageing and DR, together 
with the expression of pro-inflammatory cytokines TNFα, IL-6, 
IL-1β, and senescence markers p16 and p21. We also analysed 
AMPK activity which is an important signal transduction 
pathway implicated in the regulation of physiological processes 
of DR (23). AMPK activation is thought to be able to inhibit 
inflammatory responses (24)and plays a central role in the 
regulation of whole body energy homeostasis and functions as a 
key regulator of intracellular fatty acid metabolism (25-28).
Materials and Methods
Unless otherwise stated, all reagents were obtained from 
Sigma (Sigma-Aldrich, UK).
Mice and treatments
Male mice used were of the C57Bl/6 (ICRFa) genotype 
(22, 29), an inbred strain previously kept as an ageing mouse 
colony at the Campus for Ageing and Vitality. They were 
housed in 56cm x 38cm x 18cm cages (North Kent Plastics, 
UK), each holding 4-6 mice. All were provided with paper 
bedding, sawdust and water, with temperature at 20°C and a 
12 hour light/dark photoperiod as described in Cameron et al. 
(30). Standard rodent chow pellets (Special Diets Services, UK) 
were provided to ad libitum (AL) fed mice as described in the 
above paper, while DR consisted of a 26% reduced intake for 
2.5 months starting at 15 months of age (22). The project was 
approved by the Faculty of Medical Sciences Ethical Review 
Committee, Newcastle University. It was licenced by the UK 
Home Office (PPL 60/3864) and complied with the principles 
for the care and use of laboratory animals.
Tissue processing
Visceral fat tissue was obtained from mice corresponding to 
5 age groups – 5 months, 17.5 months, 17.5 months DR, 24.7 
months and 30 months (for histology and immunofluorescence) 
or 33.5 months (frozen tissue samples), respectively. Visceral 
abdominal fat was removed during dissection, either snap 
frozen or fixed in 4% paraformaldehyde (PFA) and embedded 
in paraffin. For all analysis methods, at least 3 mice per group 
were used.
Histology and immunohistochemistry
Paraffin sections were cut at 5 μm thickness. Slides were 
dewaxed and hydrated in Histoclear, 100% methanol, 90%, 
70%, and dH2O for 5 minutes each, twice. The slides were then 
microwaved in citrate buffer for 4 minutes on high power, and 
10 minutes at 40% power.
Haematoxylin and Eosin staining
A standard haematoxylin (Mayer’s) and eosin staining 
technique was used (31). After drying, slides were mounted 
with DPX mounting agent (Leica Biosystems, Germany) and 
visualised using a Nikon Eclipse E800 microscope (Nikon, 
Japan) at 200x magnification. 7-14 images were taken of 
different areas on each slide. 
CD68/Nova Red staining, imaging and analysis
Following antigen retrieval, the samples were washed with 
PBS and placed in 0.9% H2O2 for 30 minutes. The samples 
were washed and blocked for 30 minutes (5% NGS, 1% BSA 
in PBS). The samples were then rinsed with PBS and blocked 
with an avidin/biotin solution (SP-2001, Vector Laboratories, 
USA). The samples were then incubated overnight at 4°C in 
1:100 of CD68 primary antibody (ab125212, Abcam, UK) in 
blocking solution (5% NGS, 1% BSA in PBS). The samples 
were then washed three times and incubated for 1 hour at 
room temperature in 1:200 of biotinylated anti-rabbit antibody 
(Vectastain ABC kit, Vector laboratories, USA) in blocking 
solution. The AB complex (Vectastain ABC kit) was then 
applied to the samples for 30 minutes. The samples were then 
washed three times. Nova Red (Vector Laboratories, USA) 
was then applied to the samples for exactly 2 minutes. Nova 
Red was rinsed off with water and methyl green (0.2% in 
dH2O, Sigma-Aldrich, UK) was applied to the samples for 10 
minutes. The samples were then briefly rinsed with water and 
dehydrated in 70%, 95%, 100% methanol and Histo-Clear for 
30 seconds at each step. The samples were mounted in DPX 
(Leica Biosystems, Germany) and stored at room temperature.
Bright field imaging was performed for the Nova Red 
staining using a Nikon E800 wide-field microscope (Nikon, 
Japan) at 200x magnification. Images were analysed using 
ImageJ and the cell counter plugin. The areas and perimeter of 
whole cells stained by H&E were traced and measured using 
ImageJ.
Macrophages, aggregates, and crown-like structures (CLS) 
were counted using ImageJ. CLS were considered as aggregates 
as well. CLS always contain fat molecules in the middle 
surrounded by macrophages due to the digestion of adipocytes.
Immunofluorescence analysis
Slides were dewaxed and hydrated in Histoclear, 100% 
methanol, 90%, 70%, and dH2O for 5 minutes each, twice. The 
slides were then microwaved in citrate buffer for 4 minutes on 
high power, and 10 minutes at 40% power. 
The slides were then washed in PBS for 15 minutes thrice 
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and incubated in blocking solution (5% NGS, 1% BSA in PBS) 
for 1 hour. The sections were then incubated with 100 μl rabbit 
primary γH2A.X antibody (Cell Signalling Technologies, USA) 
at 1:250 in PBS mix with the same concentrations of NGS and 
BSA as above overnight at 4˚C. The samples were then washed 
with PBS for 15 minutes thrice and incubated with 100 μl goat 
anti-rabbit secondary antibody (AlexaFluor 488; Molecular 
Probes, UK) at 1:1000 5% NGS, 1% BSA PBS mix for 1 hour. 
The sections were then washed with PBS for 15 minutes thrice 
and incubated with 100 μl of DAPI (Partec, Germany). After a 
10 minute wash, the sections were mounted with Vectashield 
(Vector Labs, USA). The slides were imaged using a wide-field 
fluorescence microscopy (Leica DMi8, Leica Microsystems, 
Germany) at 630x and 1000x magnification. All images were 
obtained as z-stacks with 0.45 μm thickness to encompass the 
entire depth of the cell, which took between 15 and 30 steps. 
The images were then processed using ImageJ. For γH2A.X, 
the blurred images at either extremes of the z-focus were 
removed. Remaining images were compressed onto one plane 
and the total foci in each nucleus was counted across 7 z-stacks 
(fields of capture). Each nucleus was also marked as positive 
or negative for foci. Percentage nucleus positive for foci, and 
average foci per nucleus were then determined.
RNA extraction and Reverse Transcription
Up to 100 mg of whole frozen tissue samples were 
powderised by mortar and pestle in liquid nitrogen before 
RNA extraction using the Qiagen RNeasy Lipid Tissue 
Mini Kit (Qiagen, Belgium). The concentration of RNA 
obtained from the fat tissue was quantified using a Nanodrop 
spectrophotometer (ND-1000, Thermo Scientific, USA). 1 μg 
of RNA was then added to 1 μl of Random Primers (Thermo 
Scientific, USA) and made up to a final volume of 11 μl in 
nuclease-free water. RNA was denatured for 7 minutes at 75°C 
in a PCR Sprint Thermal Cycler (Hybaid, Germany) and briefly 
cooled on ice. 4 μl of 5x First Strand Buffer (Invitrogen, UK) 
and 2 μl of 0.1 M DTT (Invitrogen, UK) were then added to 
the PCR tube, along with 1 μl 10 mM dNTP mix (Biolabs, 
USA), 1 μl RNase Inhibitor (Promega, USA) and 1 μl Reverse 
Transcriptase (Superscript III; Invitrogen, USA) to a final 
volume of 20 μl. The reverse transcriptase mixture was then 
incubated at 42 ˚C for 90 minutes in the Thermal Cycler, 
inactivated at 95 ˚C, and the resulting cDNA stored at -70 ˚C. 
Quantitative PCR
Each sample and negative control was measured in triplicate. 
For each well on a 96-well qPCR plate (Applied Biosystems, 
USA), 5 μl of Sybr Green (SensiFAST SYBR Hi-ROX kit, 
Bioline, UK), 0.5 μl each of 10 μM forward and reverse primers 
(Table 1) diluted 1:10 in nuclease free water, and 3 μl of 
nuclease free water (Qiagen, Belgium) was added to a 500 
μl microfuge tube. 9 μl of this mastermix was added to each 
well, along with 1 μl of sample cDNA. Amplification was 
performed with the following program: 1 cycle at 95 ˚C for 2 
min, 50 cycles at 95 ˚C for 5 s and 60 ˚C for 30 s, 1 cycle at 
95 ˚C for 15 s, 60 ˚C for 1 min, and 95 ˚C for 15 s. Non-POU 
domain-containing octamer binding protein, encoded by Nono, 
was used as the internal fat-specific housekeeping gene [32]. 
Values were expressed as a 2-ΔΔCt average for each sample, as 
previously described (33). Mean and SEM were then calculated 
for each group of mice.
Western blotting
Protein concentrations of samples lysed in CHAPS buffer 
were determined using Bradford reagent (BioRAD, USA).
The Western blot protocol used was described previously 
(38). A 10% resolving gel was used. 50 μg of protein were 
loaded per well. Primary antibodies against total AMPK and 
phosphorylated AMPK (1:750 phosphorylated AMPK and 
total AMPK, Abcam, UK) were used. Western blot images 
were acquired using the LAS4000 imager (GE Healthcare Life 
Sciences, USA). Total AMPK and phosphorylated AMPK were 
acquired at 20 seconds. The intensity and background of each 
band was then measured using the AIDA software (Raytest). 
Phosphorylated AMPK intensities were then divided against 
total AMPK to obtain the ratio of phosphorylated AMPK vs 
total AMPK.
Statistical Analysis
Statistical analysis was performed using SigmaPlot 12.5 
(Systat Software Inc, USA). All data sets were tested for normal 
distribution using Mann-Whitney rank sum test, then analysed 
with One Way ANOVA, and either Dunn’s, Holm- Sidak, or 
Tukey’s tests post-hoc tests for pairwise comparisons.
The mean of normally distributed data is presented in bar 
charts with standard error (n=3), whereas data lacking normal 
distribution is presented as individual entries in box and 
whisker plots.
Table 1
Primer sequences used in qPCR
Primer Name Forward Sequence Reverse Sequence
Nono (32) TGCTCCTGTGCCACCTGGTACTC CCGGAGCTGGACGGTTGAATGC
p16 (34) CCCAACGCCCCGAACT GCAGAAGAGCTGCTACGTGAA
p21 (35) GCCTTAGCCCTCACTCTGTG AGCTGGCCTTAGAGGTGACA
TNF-α (36) ACGTGGAACTGGCAGAAGA CTCCTCCACTTGGTGGTTTG
IL-6 (37) TGTATGAACAACGATGATGCACTT ACTCTGGCTTTGTCTTTCTTGTTATCT
DIETARY RESTRICTION AMELIORATES AGE-RELATED INCREASE IN DNA DAMAGE, SENESCENCE & INFLAMMATION
J Nutr Health Aging
Volume 22, Number 4, 2018
558
Results
Changes in visceral adipocyte size
Histological analysis showed an increase in adipocyte size 
during ageing from 5 months old mice until 17.5 months (see 
Figure 1A for representative images). As expected, adipocyte 
area (Figure 1B) and perimeter (Figure 1C) correlated very well 
with each other (R2=0.967). In contrast, at higher age (around 
25 months) adipocyte size got smaller and was comparable to 
the young group (Figure 1B, C). Surprisingly, adipocytes at 
very old age around 30 months were even smaller than in young 
mice. Thus, the adipocyte size did not just follow the pattern of 
body weights for the respective age groups (Figure 1D). Short 
term DR resulted in a significant decrease in adipocyte size at 
17.5 months and was comparable to adipocytes from 5 month 
old mice corresponding to their reduced body weight which was 
also similar to that of young mice at 5 months of age.
Figure 1
Differences in area and perimeter in adipocytes and body 
weights from young, old and DR mice 
A) H&E staining of adipocytes from 5 months, 17.5 months AL, 17.5 months DR, 24 
months, and 30 months old mice. Images were taken at 400x magnification. B) Area of 
adipocytes at different ages and feeding conditions. Data are shown as means and SEM 
from 3 mice per age group. C) Perimeter of adipocytes at different ages and feeding 
conditions. Data are shown as means and SEM from 3 mice per age group * P<0.05 all 
are significantly different from 17.5m AL. $ P<0.05 all groups are significantly different 
from 30m. D) Body weight of mice from the different age and treatment groups. Number of 
mice per group was between 7 and 10 except for the 25 months old where only 3 mice were 
used. 17.5mAL and 25m old mice were significantly different from young mice at 5m in an 
ANOVA on ranks analysis. *p<0.05.
DNA damage and expression of senescence markers in 
visceral WAT
We have previously shown that γH2A.X DNA damage foci 
can be used as marker to characterise senescence in tissues 
(22, 39). Thus, we quantified changes in the percentage of 
cells harbouring DNA damage foci (Figure 2A) as well as the 
average number of foci per nucleus during ageing and DR in 
visceral WAT (Figure 2B). As expected from other tissues 
such as liver and gut (22) the percentage of γH2A.X positive 
cell nuclei increased with age up to 25 months with no further 
increase at 33 months of age (Figure 2A). In contrast, the 
17.5 month DR visceral WAT showed a significantly reduced 
amount of γH2A.X-positive cells compared to 17.5 month AL.
Figure 2
DNA damage and expression of senescence markers in 
adipocytes from young, old and DR mice 
A, B:  Quantification of DNA damage γH2A.X foci. A) Percentage of adipocytes 
displaying γH2A.X foci. 250-400 cells were analysed per group. Data are shown as means 
and SEM from 3 mice per group. B) Average number of foci per cell. 250-400 cells 
were analysed per group. Data are shown as means and SEM from 3 mice per age group. 
& P<0.05 these groups are different from 5m and 17.5m DR Samples were compared 
using one way ANOVA with Holm-Sidak pairwise comparisons as post-hoc test. C, D: 
expression of senescence markers.  C) p16 expression, D) p21 expression. Data are shown 
as means and SEM from 3 mice per age group. The different groups and treatments were 
compared using one way ANOVA with Holm-Sidak pairwise comparisons as post-hoc test. 
* P<0.05
The average number of foci per cell in general correlated 
well with age between 5 months and 25 months (Figure 2B). 
However, at 30 months of age the foci number decreased to 
levels similar to those in adipose tissue from 17.5 months old 
mice under AL.
A similar pattern was seen for expression changes of the 
senescence marker p16 and p21; they tended to increase with 
age up to 25 months but to decrease in the fat tissues from 
the very old (33 months) animals, and they tended to be lower 
following DR, although the changes were not always significant 
(Figure 2 C, D).
Expression of inflammation markers
Inflammation is an important hallmark of aged adipose 
tissue (40). Thus, we analysed the expression levels of various 
inflammation markers in visceral fat tissue from mice at 
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different ages and under short term, late onset DR. All markers 
tended to increase with age and to decrease under DR. In 
contrast to the senescence markers (Figure 2), there was no 
tendency for inflammation to decrease in very old age (Figure 
3A-C). 
Figure 3
Expression of inflammation markers in visceral WAT from 
young, old and DR mice
A) TNFα, B) IL-6, C) IL-1β. Expression is shown as 2-ΔΔCt with SEM, and the different 
groups and treatments were compared using one way ANOVA with Holm-Sidak pairwise 
comparisons as post-hoc test. * P<0.05
Macrophage infiltration into visceral fat
In order to complement our expression analysis of 
inflammation markers in adipose tissue we also analysed 
macrophage infiltration into WAT. Infiltrating macrophages are 
known to be responsible for WAT inflammation, in particular 
the production of IL-6 (41).
Macrophage infiltration into WAT was detected using an 
antibody against the macrophage transmembrane marker CD68. 
Representative images including a negative control without 
the antibody showing only the histological stain with methyl 
green as well as a positive control of an artery filled with 
macrophages are shown in fig. 4A. There were no significant 
differences in macrophage infiltration, aggregate number or 
CLS formation at younger ages or due to DR. However, we 
found a significantly increased amount of single macrophages 
at 24.7 months which tended to decrease again after that to 
lower levels at 30 months (Figure 4B). Probably, this late 
decrease was due to an increased formation of aggregates 
(Figure 4C) and, possibly, crown like structures (Figure 4D) at 
30 months of age.
AMPK activation
AMPK activity is regulated via AMPK phosphorylation 
by decreased energy (ATP) and an increased AMP level. 
In addition, in adipocytes AMPK can be activated by 
adipocytederived hormones such as leptin and adiponectin (42).
We found a general trend for AMPK phosphorylation/ 
activity to increase during ageing reaching significance at the 
highest age (Figure 5B). There was no significant increase yet 
at 17.5 months and no change under DR.
Discussion
As adipocytes enlarge during obesity and ageing (6, 11) 
adipose tissues undergo molecular and cellular alterations 
affecting systemic metabolism. Small adipocytes in lean 
individuals promote metabolic homeostasis while the enlarged 
adipocytes of obese and aged individuals recruit macrophages 
and promote inflammation and the release of various factors 
predisposing toward insulin resistance (43).
Figure 4
Analysis of CD68 macrophage infiltration into adipose tissue of 
different ages and feeding conditions
A: Representative images of IHC staining in mouse 5 month, 17.5 month AL and DR, 
24 month and 30 month visceral fat sections. Red arrows: macrophage aggregates, black 
arrows: CLS. Methyl green only serves as a negative control in order to demonstrate the 
specificity of the Nova Red signal. Positive control: CD68 stained readily in adipose tissue 
arteries. White arrows show the dark Nova-Red signal. Dark signals:  Nova Red CD68 
macrophage staining. Blue/Green = Methyl green, Red/Brown = CD68. B: Macrophage 
numbers per 100 adipocytes. C: Numbers of macrophage aggregates (including CLS) 
per 100 adipocytes. D: Numbers of Crown-like structures per 100 adipocytes. Data are 
shown as mean and SEM from 3 mice per group. The different groups and treatments were 
compared using one way ANOVA with Holm-Sidak pairwise comparisons as post-hoc test 
or an ANOVA on ranks analysis. * P<0.05
Figure 5
AMPK phosphorylation in visceral WAT from young, old and 
DR mice
A: upper row:  Blots for visceral fat tissue at 5.5, 25 and 33.5 month old mice showing 
p-AMPK and total AMPK at 65 KD. Lower row:  Blots for visceral fat tissue of 
17.5 month old AL and DR mice showing p-AMPK and total AMPK. B:  Ratio of 
phosphorylated vs total AMPK. Data are shown as mean with SEM from 3 mice per group. 
Significance was calculated by ANOVA and pairwise comparisons using a Holm-Sidak 
post-hoc test. * P<0.05 
Changes in adipocyte size occur during ageing, and our data 
confirms this finding for middle-aged mice at 17.5 months 
while it decreased to comparable sizes as in young mice in 
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higher age groups. This finding corresponds to that from others 
(6) who found a decrease of adipocyte size in subcutaneous 
and gonadal fat from C57BL6 mice correlating to lower body 
weight at 24 months. Our mouse strain is particularly long lived 
(44) and thus their body weight decreases only at a higher age.
Others have found that telomere lengths in adipocytes was 
inversely correlated to adipocyte size and waist circumference 
in obese subjects (45). However, our results suggest that 
adipocyte size per se is not a good marker for measuring 
agerelated changes in WAT of mice at higher ages. A reason for 
this could be a re-distribution of fat in the body during ageing 
due to increased triacylglyceride accumulation in the liver and 
less in subcutaneous fat (46). Liver steatosis due to ageing and 
cellular senescence can be greatly prevented and ameliorated 
with dietary restriction and pharmacological eradication of 
senescent cells in the liver (47).
DR was able to significantly reduce adipocyte size and 
multiple marker of adipocyte senescence (significant for DNA 
damage, p21 and IL-6 expression). This indicates that DR acts 
as a senolytic treatment in visceral fat, similar to its effects in 
other tissues like liver, intestine or corneal epithelium (22, 47, 
48). There was no change in frequencies of single or aggregated 
macrophages under DR and only a tendency towards a decrease 
in CLS from a rather low level, suggesting that DR reduces 
frequencies of senescent adipocytes not by activating their 
immuno-surveillance, at least not macrophagemediated 
immuno-surveillance. This is in contrast to the transient 
increase in macrophage infiltration due to increased lipolysis 
during weight loss and fasting of obese mice found by others 
in perigonadal WAT (49). However, it is known that different 
fat depots can react differently to dietary interventions such 
as DR (50) and that both senescent cell frequencies (5) and 
IL-6 secretion (51) are higher in visceral than in peripheral 
or subcutaneous fat depots. Moreover, the effects of DR on 
adipocyte senescence and pro-inflammatory cytokines were 
not associated with different activation of AMPK. This result 
is in contrast to data from others who described an increase in 
AMPK activation after short term DR (5 weeks) in genetically 
obese mice (52). Likewise, other have found a decrease of 
activated AMPK in epididymal WAT from obese mice and wild 
type mice fed a high fat/high sucrose diet for 4 months (53).
In hepatocytes and fibroblasts, DR may suppress induction 
of senescence by improving mitochondrial fatty acid turnover 
(47). A similar mechanism appears possible for adipocytes. 
Targeted organism-wide depletion of senescent cells (including 
WAT) normalised various tissue parameters including 
expression of adipogenesis markers to that of young mice 
(3). Together, this suggests that important metabolic benefits 
of DR, including improvements in glucose tolerance and 
insulin resistance, might be mediated by reduction of adipocyte 
senescence. The effect of nutritional interventions such as 
by feeding mice a high fat diet on the increase of adipocyte 
size, senescence markers (p21, p53 and p16) as well as pro-
inflammatory SASP factors (including IL-6) in visceral fat 
tissue has been recently shown by Schafer et al. (20). The 
authors also showed a decrease of the senescent phenotype by 
exercise.
In contrast to our expectations and to the continuous increase 
of senescent cell frequencies up to very old age (42 months) in 
liver and intestine of mice (54, 55), we here observed decreases 
in several markers of adipocyte senescence at advanced age 
(30 – 33 months), but no decrease in the expression levels of 
multiple pro-inflammatory cytokines and a continuing increase 
in AMPK phosphorylation. To our knowledge so far AMPK 
activity in visceral fat from old mice has not yet been described 
and we were surprised to see an increase there. We speculate 
that this could be associated to lower adipocyte size at higher 
ages (see figure 1).
At the same time, there were high numbers of infiltrating 
macrophages, many of which were aggregated or forming CLS, 
which might be responsible for the continuously high levels 
of inflammation mediators. These macrophages could also be 
responsible for the removal of cells with very high amounts of 
DNA damage foci (see fig. 2B). This data might indicate that 
macrophages in visceral fat need a relatively high threshold 
of signals from senescent adipocytes to become activated, 
and that this threshold is only reached at very advanced age. 
Alternatively, increased AMPK activation at old ages might 
drive fatty oxidation, lipolysis and redistribution of fatty acids 
to liver (6, 46, 47, 56). A more comprehensive analysis of 
SASP and macrophage-derived inflammation markers would be 
required to draw a definitive conclusion.
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